High energy cyclotron market seen reaching $1.63 billion by 2030

The high energy cyclotron market is forecast to grow from $1.08 billion in 2025 to $1.63 billion by 2030, driven by rising cancer cases, medical isotope demand and new research investments. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - High energy cyclotrons support cancer diagnostics, medical isotope production and advanced radiation therapies. - Rising cancer incidence is expanding demand for the machines across hospitals, research labs and nuclear medicine programs. - The market’s growth outlook signals more spending on accelerator technology, oncology infrastructure and radiopharmaceutical supply chains.

What happened: - The Business Research Company released its "High Energy Cyclotron Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035" on July 17, 2026. - The report values the market at $1.08 billion in 2025 and projects $1.17 billion in 2026. - The report forecasts the market will reach $1.63 billion by 2030. - The report projects an 8.4% CAGR for 2025-2026 and an 8.7% CAGR through 2030. - The report includes a free sample here. - The full report is available here.

The details: - A high energy cyclotron is a particle accelerator that uses magnetic and electric fields to move charged particles in a spiral path to very high energies. - High energy cyclotrons can use synchrocyclotron or isochronous operation to reach higher particle energies than traditional cyclotrons. - The report cites medical isotope production, oncology research, particle physics experiments and adoption in academic and research institutions as past growth drivers. - The report identifies cancer treatment technologies, nuclear medicine, radiopharmaceutical investment, precision oncology, government research infrastructure and scientific research adoption as future growth drivers. - Emerging trends include greater use in cancer radiotherapy and oncology studies, compact systems for isotope production, precision beam control, new nuclear physics and material science facilities, and automation for safety and efficiency. - In 2025, North America held the largest market share. - Asia-Pacific is expected to grow the fastest over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The cancer driver matters because aging populations are increasing the number of patients who need advanced treatment. - The report cites a National Library of Medicine estimate from September 2025 that the global cancer burden will rise 60.7% between 2024 and 2050, from 19 million to 30.5 million cases. - That projected rise strengthens the case for more isotope production capacity and more proton-beam infrastructure. - The regional split suggests mature demand in North America and faster buildout in Asia-Pacific.

What's next: - The market is likely to keep moving toward higher-efficiency systems and more automated controls. - Growth should track continued investment in oncology, nuclear medicine and research infrastructure. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspots infographics, key technologies and future trends, plus updated graphics and tables. - The company says it offers 30,000+ reports across 27 industries and 60+ geographies, supported by 1,500,000 datasets and its Global Market Model platform.